Ixolaris (University of Rhode Island/NIAID)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIxolaris (University of Rhode Island/NIAID)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Rhode Island
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthUniversity Of Rhode IslandNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsLyme Disease

Other Information

ATC CodeN/A
Related LinksN/A